http://chineseinput.net/에서 pinyin(병음)방식으로 중국어를 변환할 수 있습니다.
변환된 중국어를 복사하여 사용하시면 됩니다.
A dense, pinholes-free pure cubic phase CsPbBr3 nanocrystals film for high-performance photodetector
Thanh-Tung Duong,Phuong-Nam Tran,Tuan-Pham Van,Duy-Hung Nguyen,Van-Dang Tran 대한금속·재료학회 2024 ELECTRONIC MATERIALS LETTERS Vol.20 No.2
This study demonstrates a simple centrifugal coating method to prepare high-quality pure cubic phase CsPbBr 3 nanocrystalfi lm. The resultant perovskite layers possess a uniform and dense 500 nm-thick, with a bandgap of 2.38 eV, a low trap-statedensity of 6.9 × 10 − 15 cm − 3 , and carrier mobility of approximately 19.8 cm 2 V − 1 s − 1 . Furthermore, CsPbBr 3 NCs-basedself-powered photodetectors with high charge carriers’ charge transfer are fabricated. The device shows a low dark currentdensity of 1.93 × 10 − 7 A/cm 2 at room temperature. Such photodetectors show the highest responsivity of 3.0 AW − 1 ,specifi c detectivity of 1.2 × 10 13 Jones, and external quantum effi ciency (EQE) of 920% at zero bias voltage. The proposedmethod shows signifi cant promise for use in the lab fabrication of optoelectronic devices based on thin fi lms of nanocrystalperovskite materials.
Tran, Tuan Hiep,Nguyen, Hanh Thuy,Pham, Tung Thanh,Choi, Ju Yeon,Choi, Han-Gon,Yong, Chul Soon,Kim, Jong Oh American Chemical Society 2015 ACS APPLIED MATERIALS & INTERFACES Vol.7 No.51
<P>Despite tremendous progress in chemotherapy, drug resistance remains a major challenge for anticancer treatment. The combinations of chemo-photothermal and chemo-chemo treatments have been reported to be potential solutions to overcome drug resistance. In this study, we developed a dual-in-dual synergistic therapy based on the use of dual anticancer drug-loaded graphene oxide (GO) stabilized with poloxamer 188 for generating heat and delivering drugs to kill cancer cells under near-infrared (NIR) laser irradiation. The nanocomparable system is stable and uniform in size, generating sufficient heat to induce cell death. Dual drugs (doxorubicin and irinotecan)-loaded GO (GO-DI) in combination with laser irradiation caused higher cytotoxicity than that caused by the administration of a free single drug as well as a combination of drugs and blank GO in various cancer cells, especially in MDA-MB-231 resistant breast cancer cells. Exposure to “hot” NIR and GO-DI activated the intrinsic apoptosis pathway, which was confirmed based on changes in the morphology of cell nuclei and overexpression of apoptosis-related proteins. On the basis of the results, the combined treatment showed a synergistic effect compared to the effect of chemotherapy or photothermal treatment alone, demonstrating higher therapeutic efficacy to overcome one of the most severe problem in anticancer therapy, that of intrinsic resistance to chemotherapeutics.</P><P><B>Graphic Abstract</B> <IMG SRC='http://pubs.acs.org/appl/literatum/publisher/achs/journals/content/aamick/2015/aamick.2015.7.issue-51/acsami.5b10426/production/images/medium/am-2015-104266_0005.gif'></P>
Tran, Tuan Hiep,Tran, Thi Thu Phuong,Truong, Duy Hieu,Nguyen, Hanh Thuy,Pham, Tung Thanh,Yong, Chul Soon,Kim, Jong Oh Elsevier Science B.V. Amsterdam 2019 ACTA BIOMATERIALIA Vol. No.
<P><B>Abstract</B></P> <P>The expression of Toll-like receptors (TLRs) on antigen presenting cells, especially dendritic cells, offers several sensitive mediators to trigger an adaptive immune response, which potentially can be exploited to detect and eliminate pathogenic objects. Consequently, numerous agonists that target TLRs are being used clinically either alone or in combination with other therapies to strengthen the immune system in the battle against cancer. This review summarizes the roles of TLRs in tumor biology, and focuses on relevant TLR-dependent antitumor pathways and the conjugation of TLR agonists as adjuvants to nano- and micro-particles for boosting responses leading to cancer suppression and eradication.</P> <P><B>Statement of Significance</B></P> <P>Toll-like receptors (TLRs), which express on antigen presenting cells, such as dendritic cells and macrophages, play an important role in sensing pathogenic agents and inducing adaptive immunity. As a result, several TLR agonists have been investigating as therapeutic agents individually or in combination with other treatment modalities for cancer treatment through boosting the immune system. This review aims to focus on the roles of TLRs in cancer and TLR-dependent antitumor pathways as well as the use of different nano- or micro-particles bearing TLR agonists for tumor inhibition and elimination.</P> <P><B>Graphical abstract</B></P> <P>[DISPLAY OMISSION]</P>